When Did the Mounjaro Price Increase Take Effect — and What Does It Mean for You?

What Lilly's official price change actually showed

Eli Lilly's decision to raise Mounjaro's UK list price from 1 September 2025 was widely reported across health and financial press in August 2025. The headline figure most outlets cited was the jump at the 15mg level: from roughly £122 to roughly £330 per four-week pen. Lower doses saw smaller absolute increases, though the proportional rise was still significant across the board. These are list prices, the wholesale benchmark from which private pharmacies and clinics derive their own retail pricing. They are not a fixed ceiling or floor. As a result, what a patient pays through a private weight-loss service from September 2025 onward reflects both the new list price and the individual provider's own margin, service structure, and what is bundled in.

If you have been searching for when the Mounjaro price increase date was set, the short answer is 1 September 2025. For a full breakdown of what that shift looked like across each dose, our Mounjaro price increase overview covers it dose by dose with the sourced figures. The broader question of why Lilly made this move (manufacturer pricing strategy, supply normalisation, NHS list-price alignment) is addressed separately in our piece on the reasons behind the increase.

What headline prices typically leave out

Since September 2025, it has become more common to see private Mounjaro prices advertised at a monthly figure without clear detail of what that figure covers. This matters more now that the base cost of the medicine itself has risen sharply. A price that looks lower at first glance may exclude clinical consultation (sometimes charged separately, sometimes bundled only for the first month), the prescription itself, delivery, and any aftercare or dose-review support between orders. Add those elements back and the effective monthly cost is often closer to the headline prices of services that include them from the start.

It is worth checking, before committing to any provider, whether a follow-up clinical review is included when you want to move up a dose. At 5mg, for example, a prescriber needs to satisfy themselves that the previous dose was tolerated before approving an increase. Our page on the 5mg dose and the price shift looks at this in practical terms. Similarly, patients coming off the starter dose will find context on the 2.5mg price picture useful for understanding what the entry point now costs versus what it did before September 2025.

Why cheapest is not the right measure for a prescription medicine

For most purchases, comparing on price is sensible. For a prescription-only medicine, the lower price often signals something missing rather than something gained. Since September 2025, price pressure on providers has increased, and so has the incentive for some sellers to cut corners. The MHRA has warned consistently about fake weight-loss pens sold online, in October 2025, a site producing counterfeit tirzepatide pens was raided in Northampton, adding to roughly 20 million doses of illegally traded weight-loss medicines seized across 2025 alone, with an estimated street value of around £45 million. You can report a suspect seller via the MHRA Yellow Card service and verify any online pharmacy at the GPhC register before placing an order. A clinically reviewed prescription, dispensed through a GPhC-registered pharmacy, from the licensed UK supply chain: those are the things that keep you safe. Price is the wrong test for that.

You can also check whether any pharmacy is legitimate by looking up their GPhC premises registration, ours is 9012878, verifiable directly at the GPhC register. For a broader grounding in how Mounjaro works, what the evidence says and what to discuss with a prescriber, our Mounjaro treatment guide is the place to start.

How nume positions its pricing after the September 2025 change

We are not the cheapest. That is deliberate. After the list price rose on 1 September 2025, we chose not to absorb the increase by stripping out parts of the service. One transparent price still covers the consultation, the prescription, the treatment, and free next-working-day tracked delivery by DPD, every order arriving in plain, unbranded packaging. A named prescriber (not a piece of software) reads your consultation the same day. There are no subscriptions. No auto-renewals. Every repeat goes through a fresh clinical review before it is approved, which is how prescribing should work. Our treatment page shows current pricing for each dose.

If you want to understand how our clinical team approaches treatment decisions, including what they look for at dose reviews, the clinical team profile gives a clear picture. And if post-September pricing at a specific dose is your main concern, our overview of Mounjaro costs in the UK is the most detailed resource we publish on the subject, including what the changes meant for patients already mid-treatment.